... by investigating the association between tissue TLRs and plasma CRP. Methods: Tissue expressions of TLR2, TLR4, TLR5, and TLR7 were assessed using immunohistochemistry of tissue microarray slides from 549 CRC patients surgically treated between 1998 and 2005. Blood samples were drawn preoperatively, centrifuged...

..., instructions or products referred to in the content or advertisements. Biomarkers Prognosis Cervical cancer Immunohistochemistry Inflammation Thrombocytosis Interleukin-6 Platelet to lymphocyte ratio Data were analyzed using SPSS (SPSS, Inc., Chicago, IL, USA). Categorical variables were...

... immunohistochemistry, we analyzed tissue microarray samples from 825 CRC patients who underwent surgery between 1982 and 2002 at the Department of Surgery, Helsinki University Hospital, Finland. After analyzing a pilot series of 205 tissue samples, we included only TLR5 and TLR7 in the remainder of the patient series...

.... We used immunohistochemistry to assess the expression of TKTL1 and GLUT1, combined with clinicopathological data. Results: Positive expression of TKTL1 was associated with positive expression of GLUT1, age over 65 years, male gender, advanced stage (II–IV), and advanced tumors (T2–T4). Patients...

... The histopathology of IDC was evaluated according to current WHO classification and patients were classed according to TNM classification [ 3 ]. Estrogen receptor (ER), progesterone receptor (PR), and Ki-67 expression was studied by immunohistochemistry as described previously [ 20 ]. Grading of NEBC was omitted...

...: Our study thus suggests the plausible role of HER-2 and p53 expression in worse prognosis of GBC in a north Indian population. Gallbladder cancer HER-2 p53 Immunohistochemistry Survival plots aknajmi@hotmail.com 20 06 2016 11 09 2016 27 10 2016 © 2016 S...

... of both the standard form of CD44st and of CD44v6 in NSCLC patients who underwent complete resection and also investigate preoperative serum CD44st (sCD44st) and CD44v6 (sCD44v6) levels as prognostic biomarkers. Lung cancer Prognosis Surgery Immunohistochemistry Serum CD44 CD44v6 Lung...

...)/PgR and HER2 status, p53 protein overexpression, and the Ki-67 index. We prepared a single representative section taken from the maximum diameter of an invasive tumor and used it for immunohistochemistry (IHC). The necrotic and/or degenerated tumor areas were not included in our cell counting system...

... cases were defined as having an immunohistochemistry score of +3. In cases of Her2-positive +2, we investigated the gene amplification by chromogenic in situ hybridization (CISH) with Her2 CISH Kit pharm Dx (Dako). Breast cancer molecular subtypes were classified according to immunohistochemical...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tumour-associated trypsin inhibitor Trypsinogen-1 Trypsinogen-2 Colorectal cancer Immunohistochemistry In cancer progression, the tumour has to invade...

... surgery were compared with respect to the separation profiles of their tryptic peptides. Immunohistochemistry was performed on 106 HCC nodules to confirm the results of the proteomic analysis. Results: Statistical analysis of the profiles selected the peptide peaks differentiating HCC from non-HCC...

... Immunohistochemistry Lapatinib Stratified medicine Targeted treatment Trastuzumab In breast cancer, HER2 status has become an important predictive biomarker for treatment with HER2 inhibitors such as the monoclonal antibody trastuzumab (Herceptin®, Roche) and the tyrosine kinase inhibitor lapatinib (Tyverb®...

... and localization plays an important role in initiation, differentiation and progression of endometrial carcinomas. Endometrium Carcinoma Hyperplasia c- myc Immunohistochemistry 30 6 2009 © 1994 S. Karger AG, Basel 1994 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...

... Ovarian cancer Immunohistochemistry Neopterin Thrombocytosis Original Paper Oncology 1995;52:400-406 Michael Uhl-Steidl3 Elisabeth Müller-Holznera Alain G. Zeim et3 Günther R. Adolf* Günter Daxenbichlera Christian Marth* Otto Dapunt* a Department of Obstetrics and Gynecology, Innsbruck University...

.... Breast cancer Estrogen receptor Heat shock protein Immunohistochemistry pS2 p53 Epidermal growth factor receptor c-erbB-2 Original Paper Oncology 1995;52:371-375 Shuji Takahashia b Eimei Narimatsua Hiroko Asanuma* Minoru Okazakic Akira Okazakic Koichi Hiratac Michio Mori* Takayuki Chibab...

... demonstrated using immunohistochemistry, but the relationship between serum c-erbB-2 level and clinical data has not been fully evaluated. In this study, serum c-erbB-2 protein levels were measured in 100 patients with pancreatic adenocarcinomas and in 9 patients with mucin-producing tumors. Immunohistochemi...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. E-cadherin α-Catenin β-Catenin Plakoglobin Esophageal cancer Immunohistochemistry ONCOLOGY Laboratory Investigation Oncology 1997;54:158-165 Yukihiro Nakanishi3...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Extrahepatic bile duct carcinoma Proliferating cell nuclear antigen p53 Immunohistochemistry ONCOLOGY Laboratory Investigation Oncology 1997;54:407-413 Takayuki Sutoa...

...Hiroyuki Takei; Yuichi Iino; Jun Horiguchi; Takao Yokoe Fibronectin (FN) in 99 female patients with invasive breast carcinomas (IBCs) was studied by immunohistochemistry using a monoclonal antibody to human plasma FN. Sixty-five (65.7%) of 99 IBCs were FN-positive and 34 (34.3%) were FN-negative...

... expression. Metallothionein Breast cancer Immunohistochemistry Cell proliferation 30 6 2009 © 1996 S. Karger AG, Basel 1996 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized...